Igor Aurer
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Lymphoma Diagnosis and Treatment 64
- Genetics 28
- Chronic Lymphocytic Leukemia Research 22
- Co-authors
- Boris Labar (26 shared papers)Ivo Radman (29 shared papers)Mirando Mršić (12 shared papers)R P Gale (1 shared paper)Zdravko Mitrović (12 shared papers)Dubravka Sertić (11 shared papers)Sandra Bašić‐Kinda (25 shared papers)Dan Nemet (7 shared papers)
- Journals
- HemaSphere (11 papers)Annals of Oncology (4 papers)Haematologica (3 papers)Annals of Hematology (3 papers)Hematological Oncology (3 papers)
- Partner nations
- CroatiaItalyNetherlands
In The Last Decade
Igor Aurer
91 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 79
- Pathology and Forensic Medicine 977
- Genetics 311
- Oncology 622
- Hematology 183
- Neurology 214
Countries citing papers authored by Igor Aurer
This map shows the geographic impact of Igor Aurer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Aurer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Aurer more than expected).
Fields of papers citing papers by Igor Aurer
This network shows the impact of papers produced by Igor Aurer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Aurer. The network helps show where Igor Aurer may publish in the future.
Co-authors
The 25 scholars most cited alongside Igor Aurer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 259 | |
| 2 | 2017 | 158 | |
| 3 | 2010 | 126 | |
| 4 | 2016 | 91 | |
| 5 | 2018 | 88 | |
| 6 | Prostaglandin E2 for prophylaxis of oral mucositis following BMT. | 1993 | 71 |
| 7 | 2015 | 58 | |
| 8 | 2007 | 48 | |
| 9 | 2022 | 46 | |
| 10 | 2012 | 43 | |
| 11 | 2022 | 40 | |
| 12 | 2019 | 40 | |
| 13 | 2018 | 38 | |
| 14 | Are new conditioning regimens for transplants in acute myelogenous leukemia better? | 1991 | 34 |
| 15 | Aberrant glycosylation of Igg heavy chain in multiple myeloma. | 2007 | 34 |
| 16 | 2016 | 26 | |
| 17 | Surgical resection in the treatment of primary gastrointestinal non-Hodgkin's lymphoma: retrospective study. | 2002 | 25 |
| 18 | 2002 | 25 | |
| 19 | 2009 | 24 | |
| 20 | What is the role of recombinant colony stimulating factors in bone marrow transplantation? | 1990 | 23 |
About Igor Aurer
Igor Aurer is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Hematology and Neurology, having authored 99 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (64 papers), Chronic Lymphocytic Leukemia Research (22 papers), Viral-associated cancers and disorders (17 papers), CNS Lymphoma Diagnosis and Treatment (10 papers), Lung Cancer Treatments and Mutations (7 papers), CAR-T cell therapy research (6 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Acute Lymphoblastic Leukemia research (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (977 citations), Genetics (311 citations), Oncology (622 citations), Hematology (183 citations) and Neurology (214 citations). Igor Aurer has collaborated with scholars based in Croatia, Italy and Netherlands. Frequent co-authors include Boris Labar, Ivo Radman, Mirando Mršić, R P Gale, Zdravko Mitrović, Dubravka Sertić, Sandra Bašić‐Kinda, Dan Nemet, Anna Sureda and Jasminka Jakić‐Razumović. Their work appears in journals such as HemaSphere, Annals of Oncology, Haematologica, Annals of Hematology and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.